sec filing
LI
NASDAQ · LIMN
Liminatus Pharma, Inc. Class A Common Stock
Healthcare · Biotechnology
$2.79
Up+$0.00 (+0.16%)
Updated Nov 5, 2026, 4:56 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 23.41M
- P/E ratio
- -9.06
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $7.48
- Volume
- 34.65K
- Avg. volume
- 630.53K
Price performance · LIMN
LIMN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
LIMN closed at $2.79 after 21 trading sessions, down 27.98% for the selected period.
- Last close
- $2.79
- Period change
- -27.98%
- Period low
- $2.52
- Period high
- $3.88
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $2.875 | $2.9499 | $2.6601 | $2.7944 | 34.65K |
| Nov 3, 2026 | $2.63 | $2.83 | $2.4035 | $2.79 | 44.86K |
| Nov 2, 2026 | $2.97 | $2.97 | $2.52 | $2.52 | 23.96K |
| Oct 30, 2026 | $2.9801 | $3.00 | $2.75 | $2.82 | 12.98K |
| Oct 29, 2026 | $3.06 | $3.14 | $2.81 | $2.895 | 28.76K |
| Oct 28, 2026 | $3.1063 | $3.1063 | $2.92 | $2.92 | 11.06K |
| Oct 27, 2026 | $2.92 | $3.01 | $2.785 | $2.89 | 24.12K |
| Oct 26, 2026 | $3.05 | $3.245 | $2.91 | $3.16 | 9.82K |
| Oct 23, 2026 | $3.10 | $3.1701 | $2.905 | $2.94 | 20.67K |
| Oct 22, 2026 | $3.19 | $3.24 | $3.10 | $3.11 | 12.77K |
| Oct 21, 2026 | $3.26 | $3.455 | $3.04 | $3.12 | 118.82K |
| Oct 20, 2026 | $3.285 | $3.295 | $3.05 | $3.22 | 33.05K |
| Oct 19, 2026 | $3.175 | $3.285 | $3.08 | $3.11 | 33.02K |
| Oct 16, 2026 | $3.30 | $3.30 | $3.01 | $3.04 | 17.08K |
| Oct 15, 2026 | $3.295 | $3.3642 | $3.21 | $3.21 | 15.85K |
| Oct 14, 2026 | $3.50 | $3.55 | $3.25 | $3.25 | 20.09K |
| Oct 13, 2026 | $3.625 | $3.625 | $3.41 | $3.41 | 13.7K |
| Oct 12, 2026 | $3.70 | $3.82 | $3.40 | $3.45 | 28.92K |
| Oct 9, 2026 | $3.5546 | $3.8098 | $3.5546 | $3.76 | 16.86K |
| Oct 8, 2026 | $3.95 | $3.95 | $3.5308 | $3.69 | 38.56K |
| Oct 7, 2026 | $3.7006 | $3.89 | $3.65 | $3.88 | 22.94K |
Latest LIMN news
The latest Smart Investors Daily articles mentioning LIMN.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…